Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 June 2022 | Story Lacea Loader
UFS drops wearing of masks on campus

The management of the University of the Free State (UFS) has taken note of the announcement by the Minister of Health, Dr Joe Phaahla, in the Government Gazette on 22 June 2022, in which COVID-19 regulations were repealed.

Minister Phaahla stated that, as from 22 June, South Africans no longer have to wear masks, and that limits on gatherings and border checks for COVID-19, as well as the need to be vaccinated in order to enter South Africa, have also been dropped.

The UFS COVID-19 Regulations and Required Vaccination Policy has created an environment that the university management regards as safe. This, together with yesterday’s announcement by the Minister, was considered, and a decision was made that the wearing of masks on campus or in any building on campus is no longer compulsory.

However, the UFS COVID-19 Regulations and Required Vaccination Policy remains in place. Campus access control is still in place, and staff, students, and visitors are expected to upload a COVID-19 vaccination certificate or a negative PCR or antigen test result to obtain access to the campuses.

The wearing of masks is still recommended and will be of value especially in the following instances:

1.     For immune-compromised staff, students, and visitors
2.     For persons who are ill with, e.g., flu, colds, coughs, etc.

In the case of staff and students working in public and private hospitals, or any other external laboratory/facility, the wearing of masks is determined by the hospital or the external laboratory/facility and not by the UFS. In any other environment where students or staff are under the regulations of external organisations, these regulations will take precedence. 

Staff and students are encouraged to feel free to continue wearing masks, including those with comorbidities, as masks have been shown to be helpful in preventing the spread of respiratory diseases. Good health-care behaviour remains important as COVID-19 is still a reality.

The university management will decide in due course on the possible upliftment of restrictions on public gatherings.

Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept